Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation - results from the Dresden NOAC registry

被引:0
|
作者
Hecker, J. [1 ]
Marten, S. [1 ]
Tittl, L. [1 ]
Beyer-Westendorf, J. [1 ]
机构
[1] Univ Hosp Dresden, Dresden, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
O101
引用
收藏
页码:201 / 201
页数:1
相关论文
共 50 条
  • [1] Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation Results from the Dresden NOAC Registry
    Hecker, Judith
    Marten, Sandra
    Keller, Loretta
    Helmert, Sindy
    Michalski, Franziska
    Werth, Sebastian
    Sahin, Kurtulus
    Tittl, Luise
    Beyer-Westendorf, Jan
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (05) : 939 - 949
  • [2] Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry
    Helmert, Sindy
    Marten, Sandra
    Mizera, Heike
    Reitter, Antje
    Sahin, Kurtulus
    Tittl, Luise
    Beyer-Westendorf, Jan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (02) : 169 - 178
  • [3] Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation Results from the Dresden NOAC Registry
    Beyer-Westendorf, Jan
    Ebertz, Franziska
    Foerster, Kati
    Gelbricht, Vera
    Michalski, Franziska
    Koehlerl, Christina
    Werth, Sebastian
    Endig, Heike
    Pannach, Sven
    Tittl, Luise
    Sahin, Kurtulus
    Daschkow, Katharina
    Weiss, Norbert
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (06) : 1247 - 1257
  • [4] Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry
    Sindy Helmert
    Sandra Marten
    Heike Mizera
    Antje Reitter
    Kurtulus Sahin
    Luise Tittl
    Jan Beyer-Westendorf
    Journal of Thrombosis and Thrombolysis, 2017, 44 : 169 - 178
  • [5] Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY
    Koehler, Christina
    Tittl, Luise
    Marten, Sandra
    Naue, Christiane
    Spindler, Marianne
    Stannek, Laura
    Fache, Kristina
    Beyer-Westendorf, Jan
    THROMBOSIS RESEARCH, 2022, 215 : 37 - 40
  • [6] Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry
    Keller, Loretta
    Marten, Sandra
    Hecker, Judith
    Sahin, Kurtulus
    Tittl, Luise
    Beyer-Westendorf, Jan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 257 : 276 - 282
  • [7] EffectiVeness and safety of rivaroxaban therapy in daily-care patients with unusual venous thromboembolism - results of the prospective dresden NOAC registry (NCT01588119)
    Tittl, L.
    Marten, S.
    Hecker, J.
    Beyer-Westendorf, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 28 - 28
  • [8] Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry
    Beyer-Westendorf, Jan
    Foerster, Kati
    Ebertz, Franziska
    Gelbricht, Vera
    Michalski, Franziska
    Tittl, Luise
    Weiss, Norbert
    BLOOD, 2014, 124 (21)
  • [9] 5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry
    Tittl, Luise
    Marten, Sandra
    Naue, Christiane
    Beyer-Westendorf, Jan
    THROMBOSIS RESEARCH, 2021, 202 : 24 - 30
  • [10] Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care - results from the Dresden NOAC registry
    Beyer-Westendorf, Jan
    Gelbricht, Vera
    Foerster, Kati
    Ebertz, Franziska
    Roellig, Denise
    Schreier, Thomas
    Tittl, Luise
    Thieme, Christoph
    Haensel, Ulrike
    Koehler, Christina
    Werth, Sebastian
    Kuhlisch, Eberhard
    Stange, Thoralf
    Roeder, Ingolf
    Weiss, Norbert
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (04) : 908 - 917